Lyra Therapeutics Inc (LYRA) stock news · rev $398.0K
Lyra Therapeutics Inc (LYRA) is a biotechnology company listed on US.
This LYRA news page leads with what Lyra Therapeutics Inc filed — not a scraped headline mill.
No cached 8-K sentence for LYRA yet. We will not pad this page with generic market recap.
Latest reported LYRA revenue for 2025-12-31 was $398.0K. Net income was -$28.9M. Revenue was down 74.1% from 2024-12-31 to 2025-12-31. LYRA currently screens at market cap $14.4M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the LYRA stock page; for the tape open the quote page.
LYRA stock news FAQ
What are LYRA's latest revenue and net income?
Latest cached Lyra Therapeutics Inc (LYRA) revenue for Dec 31, 2025 was $398.0K. Net income was -$28.9M. Statements: https://lician.com/financials/lyra
How did LYRA revenue change from the prior cached period?
Cached Lyra Therapeutics Inc (LYRA) revenue was down 74.1% from $1.5M (Dec 31, 2024) to $398.0K (Dec 31, 2025). Statements: https://lician.com/financials/lyra
What is LYRA's market cap?
Lyra Therapeutics Inc (LYRA) market cap is $14.4M on the latest cached fundamentals snapshot.
What kind of company is LYRA?
Lyra Therapeutics Inc (LYRA) is a biotechnology company listed on US.
Where is LYRA stock news listed?
Cached stock news for Lyra Therapeutics Inc (LYRA) is listed at https://lician.com/news/lyra. Filings: https://lician.com/sec/lyra
Not investment advice.